Research Papers
This database includes peer-reviewed publications authored by TB Alliance staff. Use the tags on the left to filter by subject, or search for a particular author or term using the search bar.
Tag: Pretomanid/PA-824
Displaying 58 papers
Cost and cost-effectiveness of BPaL regimen used in drug-resistant TB treatment in the Philippines
Publication: The International Journal of Tuberculosis and Lung Disease
6/2024
Prevalence and genetic basis of Mycobacterium tuberculosis resistance to pretomanid in China
Publication: Annals of Clinical Micobiology and Antimicrobials
5/2024
Bedaquiline-pretomanid-moxifloxacin-pyrazinamide for drug-sensitive and drug-resistant pulmonary tuberculosis treatment: a phase 2c, open-label, multicentre, partially randomised controlled trial
Publication: Lancet Infectious Diseases
5/2024
Global adoption of 6-month drug-resistant TB regimens: Projected uptake by 2026
Publication: PLOS One
1/2024
Baseline and acquired resistance to bedaquiline, linezolid and pretomanid, and impact on treatment outcomes in four tuberculosis clinical trials containing pretomanid
Publication: PLOS Global Public Health
10/2023
The Safety and Tolerability of Linezolid in Novel Short-Course Regimens Containing Bedaquiline, Pretomanid, and Linezolid to Treat Rifampicin-Resistant Tuberculosis: An Individual Patient Data Meta-analysis
Publication: Clinical Infectious Diseases
10/2023
Fed- and Fasted-State Performance of Pretomanid Amorphous Solid Dispersions Formulated with an Enteric Polymer
Publication: Molecular Pharmaceutics
5/2023
Next-Generation Diarylquinolines Improve Sterilizing Activity of Regimens with Pretomanid and the Novel Oxazolidinone TBI-223 in a Mouse Tuberculosis Model
Publication: Antimicrobial Agents and Chemotherapy
3/2023
Stable sugar and sugar-free suspensions of pretomanid
Publication: International Journal of Tuberculosis and Lung Disease
12/2022
Characterizing Absorption Properties of Dispersible Pretomanid Tablets Using Population Pharmacokinetic Modelling
Publication: Clinical Pharmacokinetics
11/2022
Lifesaving, cost-saving: Innovative simplified regimens for drug-resistant tuberculosis
Publication: PLOS Global Public Health
11/2022
Bedaquiline–Pretomanid–Linezolid Regimens for Drug-Resistant Tuberculosis
Publication: New England Journal of Medicine
9/2022
Assessment of the Carcinogenic Potential of Pretomanid in Transgenic Tg.rasH2 Mice
Publication: International Journal of Toxicity
7/2022
Toxicity and toxicokinetic assessment of an anti-tubercular drug pretomanid in cynomolgus monkeys
Publication: Toxicology Reports
4/2022
Ancient and recent differences in the intrinsic susceptibility of Mycobacterium tuberculosis complex to pretomanid
Publication: Antimicrobial Chemotherapy
3/2022
Acceptability, feasibility, and likelihood of stakeholders implementing the novel BPaL regimen to treat extensively drug-resistant tuberculosis patients
Publication: BMC Public Health
7/2021
Pretomanid with Bedaquiline and Linezolid for Drug Resistant TB: A Comparison of Prospective Cohorts
4/2021
A partially randomised trial of pretomanid, moxifloxacin and pyrazinamide for pulmonary TB
Publication: International Journal of Tuberculosis and Lung Disease
3/2021